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DiseasesThe endoplasmic-reticulum (ER) stress response constitutes a cellular process that is triggered by a variety of
conditions that disturb folding of proteins in the ER. Eukaryotic cells have developed an evolutionarily conserved
adaptivemechanism, the unfolded protein response (UPR),which aims to clear unfolded proteins and restore ER
homeostasis. In cases where ER stress cannot be reversed, cellular functions deteriorate, often leading to cell
death. Accumulating evidence implicates ER stress-induced cellular dysfunction and cell death asmajor contributors
tomany diseases, makingmodulators of ER stress pathways potentially attractive targets for therapeutics discovery.
Here,we summarize recent advances in understanding the diversity ofmolecularmechanisms that govern ER stress
signaling in health and disease. This article is part of a Special Section entitled: Cell Death Pathways. Guest Editors:
Frank Madeo and Slaven Stekovic.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The endoplasmic reticulum (ER) is the central intracellular organelle
in the secretory pathway. It is responsible for protein translocation,
protein folding, and protein post-translational modiﬁcations that
allow further transport of proteins to theGolgi apparatus and ultimately
to vesicles for secretion or display on the plasma surface. Perturbations
in ER function, a process named “ER-stress”, trigger the unfolded pro-
tein response (UPR), a tightly orchestrated collection of intracellular
signal transduction reactions designed to restore protein homeostasis.
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l rights reserved.named IRE1α (inositol-requiring protein-1α), PERK (protein kinase
RNA (PKR)-like ER kinase), and ATF6 (activating transcription factor
6). Under physiological conditions, the luminal domains of PERK and
ATF6 proteins are bound to the ER resident chaperone BiP (Binding im-
munoglobulin Protein), which keeps them inactive. When unfolded
proteins accumulate in the ER, BiP is released from these complexes to
assist with the folding of accumulated proteins [1]. By comparison to
the UPR modulators PERK and ATF6, which are modulated by associa-
tion with BiP, IRE1α appears to become activated when unfolded pro-
teins bind directly to it. Upon activation, PERK, IRE1α and ATF6 induce
signal transduction events that alleviate the accumulation of misfolded
proteins in the ER by increasing expression of ER chaperones, inhibiting
protein entry into the ER by arresting mRNA translation, and stimulat-
ing retrograde transport of misfolded proteins from the ER into the
cytosol for ubiquitination and destruction by a process named ERAD
(ER-assisted degradation).
This review focuses on the (a) signal transduction pathways in-
volved in the UPR and their connections to cell death mechanisms;
(b) UPR-independent mechanisms of ER stress-induced cell death,
(c) suppressors of ER stress-mediated cell death; (d) ER stress and
autophagy; and (e) diseases where ER stress plays a pathological role.2. ER stress, UPR signaling, and cell death regulation
Under conditions when ER stress is chronically prolonged and the
protein load on the ER greatly exceeds its fold capacity, cellular dysfunc-
tion and cell death often occur. Among the UPR signaling pathways
IRE1α is a keymolecule that functions as a rheostat capable of regulating
cell fate. Various studies support the concept that IRE1α binds directly to
unfolded proteins, including structural studies of the conserved core of
yeast IRE1α ER luminal domain, analysis of synthetic peptide interac-
tions with IRE1a in vitro, and protein interaction studies performed
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and off as previously believed. Instead, BiP desensitizes IRE1α to low
levels of stress and acts as a timer to modulate the response time to
the level of stress by assisting IRE1α deactivation once ER homeostasis
is reestablished. Several lines of evidence argue that alternative outputs
from IRE1α-mediated downstream signaling dictate opposing cell fates
(survival or death) during stress, which are greatly inﬂuenced by the in-
tensity and longevity of ER stress [2].
IRE1α is a transmembrane protein that consists of an N-terminal lu-
minal sensor domain, a single transmembrane domain and C-terminal
cytosolic effector that is responsible for both protein kinase and
endoribonuclease activities. Accumulation of unfolded proteins in the
ER stimulates IRE1α oligomerization in ER membranes and autophos-
phorylation of IRE1α's cytosolic domain [3]. The RNase domain processes
an intron from the X box-binding protein-1 (XBP-1) mRNA to allow pro-
duction of the XBP-1 protein. Of note, XBP-1 is not the only RNA targeted
by the RNase activity of IRE1α. For example, IRE1α also controls its own
expression by cleaving its own mRNA [4]. Moreover, IRE1α cleaves
microRNAs that control the levels of caspase family cell death proteases.
The XBP-1 protein binds to promoters of several genes involved in UPR
and ERAD (ER-assisted degradation) to restore protein homeostasis and
promote cytoprotection.
In addition to its cytoprotective function, IRE1α also stimulates acti-
vation of the Apoptotic-Signaling Kinase-1 (ASK1), which causes activa-
tion downstream of stress kinases Jun-N-terminal kinase (JNK) and p38
MAPK that promote apoptosis [5]. Among the apoptosis-inducing
substrates of JNK are Bcl-2 and Bim, which are inhibited and activated,
respectively, by JNK phosphorylation [6,7]. In addition, p38 MAPK phos-
phorylates and activates the transcription factor CHOP, which causes
changes in gene expression that favor apoptosis, including increasing
expression of Bim and DR5, while decreasing expression of Bcl-2 [8,9].
Recently, regulated IRE1-dependent decay of mRNA (RIDD) was shown
to reduce ER localized mRNAs in both insect (Drosophila) and mamma-
lian (mouse) cells [10,11]. The RIDD process selectively targets and
degrades mRNAs encoding proteins involved in protein folding.
Prolonged activation of RIDD signaling can promote cell death through
a process shown to be dependent upon the conformational state of
IRE1α. Mechanisms that mediate IRE1α-activated RIDD are still un-
known and require further investigation.
ATF6 is a transcriptional factor that upon ER stress translocates to
the Golgi compartment where it is cleaved by the action of two prote-
ases. The serine protease site-1 (S1P) cleaves ATF6 in the luminal
domain, while the N-terminal portion is subsequently cleaved by the
metalloprotease site-2 protease (S2P). The cleaved N-terminal cytosolic
domain of ATF6 then translocates into the nucleus where it binds to
ATF/cAMP response elements (CRE) and ER stress-response elements
(ERSE-1) to activate target genes such as BiP, Grp94 and CHOP. In
some cells and tissues, ATF6-like bZIP type transcription factors such
as OASIS, CREB-H, Tis40 and Luman also participate in UPR signal
transduction [12]. Interestingly, functional experiments in a model of
ischemia/reperfusion showed that ATF6 protected cardiomyocytes by
inducing expression of the protein disulﬁde isomerase associated 6
(PDIA6) gene,which encodes anER enzyme that catalyzes protein disul-
ﬁde bond formation and thus assists with protein folding in the lumen
of the ER [13,14]. Additionally, ER stress can also regulate gene expres-
sion via ATF6-mediated changes inmicro-RNA levels, where it has been
hypothesized that ATF6-mediated down-regulation of miR-455 aug-
ments expression of calreticulin which has been show to attenuate ER
stress after ischemia. Thus, this regulationmay contribute to the protec-
tive effects of ATF6 in the heart [14].
PERK is the major protein responsible for attenuation of mRNA
translation under ER stress, preventing inﬂux of newly synthesized pro-
teins into the already stressed ER compartment. This translational at-
tenuation is mediated by phosphorylation of eukaryotic translation
initiation factor 2 (eIF2α). The phosphorylation of eIF2α inhibits the
recycling of eIF2α to its active GTP-bound form, which is required forthe initiation phase of polypeptide chain synthesis. Phosphorylation of
eIF2α also allows for preferential translation of UPR-dependent genes
such as the activating transcriptional factor 4 (ATF4). Important targets
driven by ATF4 are CHOP (transcriptional factor C/EBP homologous
protein), GADD34 (growth arrest and DNA damage-inducible 34), and
ATF3. Besides elF2α, PERK can also phosphorylate nuclear erythroid 2
p45-related factor 2 (NRF2), which contributes to dissociation of the
NRF2-Keap1 complex and promotes expression of genes containing an-
tioxidant response elements (ARE), preventing oxidative stress by in-
duction of antioxidant genes such as heme oxygenase 1 (HO-1) [15].
If the various UPR-induced mechanisms fail to alleviate ER stress,
both the intrinsic and extrinsic pathways for apoptosis can become ac-
tivated (Fig. 1). Players involved in the cell death response include (i)
PERK/eIF2α-dependent induction of the pro-apoptotic transcriptional
factor CHOP; (ii) IRE1-mediated activation of TRAF2 (tumor necrosis
factor receptor associated factor 2), which stimulates the ASK1 (apopto-
sis signal-regulating kinase 1)/JNK (c-Jun amino terminal kinase) kinase
cascade, and (iii) Bax/Bcl2-regulated Ca2+ release from the ER. CHOP/
GADD153 (growth arrest/DNA damage) plays a convergent role in the
UPR and it has been identiﬁed as one of the most important mediators
of ER stress-induced apoptosis protein (reviewed by [16]). Apoptosis-
relevant targets of the CHOP transcription factor include (i) GADD34;
(ii) DR5 (TRAIL Receptor-2), a caspase-activating cell-surface death re-
ceptor of the Tumor Necrosis Factor Receptor family; and (iii) Ero1α
(endoplasmic reticulum oxidoreductase-1), which hyperoxidizes the
ER and promotes cell death. Ero1α can also activate the inositol triphos-
phate receptor (IP3R) stimulating excessive Ca2+ transport from
the ER to the mitochondria, and thereby triggering cell death [17].
CHOP-mediated activation of GADD34 promotes protein dephosphory-
lation of elF2α reversing translational inhibition [18]. Release of the
translational inhibition contributes to accumulation of unfolded pro-
teins in the ER compartment and, at the same time, permits translation
of mRNAs encoding pro-apoptotic proteins. Another possible mecha-
nism by which CHOP induces apoptosis is via direct inhibition of Bcl-2
transcription [19] and induction of Bim expression [8].
Additional ER stress-induced mechanisms contributing to cell death
may include activation of the kinase function of IRE1 involving activation
of ASK and p38 MAPK (previously discussed in this article), where p38
MAPK activates CHOP via phosphorylation of its transactivation domain
[20]. Additionally, bothp38MAPK and JNK are reported to promote phos-
phorylation and activation of pro-apoptotic protein Bax [21]. Among the
mechanisms of cell death induced by pro-apoptotic proteins Bax and Bak
[21] are their binding and pathological activation of IRE1α [22] (Fig. 1).
3. UPR independent ER stress-signaling and cell death
3.1. Calcium
The ER lumen is the major storage of intracellular Ca2+ and
Ca2+-binding chaperones mediate the proper folding of proteins in the
lumen of the ER. It is well established that Ca2+ trafﬁcking in and out
of the ER regulates a diversity of cellular responses and signaling trans-
duction pathways relevant to stress response, modulation of transcrip-
tional processes, and development. For instance, acute release of Ca2+
from the ER can trigger a variety of signaling mechanisms that promote
cell death mainly by Ca2+-mediated mitochondrial cell death [23].
Conversely, pulses of Ca2+ delivered via IP3Rs at contact sites of ER and
mitochondria promote oxidative phosphorylation, which sustains ATP
levels and cell survival [24,25]. Other proteins involved in ER
Ca2+-mediated apoptosis are Bax and Bak. Transient over-expression
of Bax results in release of ER Ca2+, with a subsequent increase in mito-
chondrial Ca2+ and enhanced cytochrome c release. In contract, cells
with deﬁciency of both Bax and Bak have reduced Ca2+ release from
ER upon stimulation with IP3 and other ER Ca2+-mobilizing agents
(Fig. 1) [25]. Calreticulin, a major Ca2+ binding ER chaperone is also a
key component for folding of newly synthesized proteins and for other
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Fig. 1. Endoplasmic reticulum (ER) stress signaling. The ER stress response is mediated by three sensors located at the ERmembrane: IRE1α, ATF6 and PERK. Accumulation of unfolded pro-
tein recruits BiP to the ER lumen and its dissociation from IRE1α, ATF6 and PERK leads to their activation. Upon dimerization and autophosphorylation, IRE1α splices XBP-1 mRNA, which
adjusts the reading frame to allow translation of an active transcriptional factor XBP-1. XBP-1 up-regulates UPR genes encoding ER chaperones and components of the ERAD machinery.
IRE1α can also recruit TRAF2 and ASK1, leading to downstream activation of JNK and p38 MAPK. Activated JNK translocates to the mitochondrial membrane and promotes (a) activation
of Bim and (b) inhibition of Bcl-2, whereas p38 MAPK phosphorylates and activates CHOP. CHOP can induce transcriptional activation of genes that contribute to cell death, including
Ero1α (hyperoxidizes the ER and activates IP3R) and DR5 (promotes caspase 8-dependent cell death). Bax and Bak can also (a) bind to and activate IRE1α and (b) induce release of Ca2+
from the ER. PERK phosphorylates elF2α and attenuates protein translation. However, translation of selected mRNAs is favored under these conditions, including ATF4, which then induces
expression of CHOP and GADD34. Activated ATF6 translocates to the Golgi where its cytosolic domain is cleaved by the proteases, S1P and S2P. The cleaved ATF6 fragment forms an active
transcriptional factor that mediates expression of several components important for protein folding, degradation, and ER expansion.
3462 R. Sano, J.C. Reed / Biochimica et Biophysica Acta 1833 (2013) 3460–3470quality control pathways of the ER. Therefore,ﬂuctuations of the levels of
Ca2+ in the ER can severely impact folding capacity and trigger cell
death. For instance, ﬁbroblasts from calreticulin-deﬁcient embryos
have impaired agonist-induced Ca2+ release and deletion of this gene
in embryos is lethal [26]. In summary, alterations in Ca2+ dynamics
seem to play an essential role not only in the ER but also some ER
stress-associated mechanisms of cell death.
3.2. MEKK1 (MAP3K4)
Recently, Kang et al. [27] have identiﬁed a new signaling pathway
where Cdk5 and MEKK1 induce apoptosis in a Drosophilamodel of ret-
initis pigmentosa, independently of the three canonical UPR branches,
IRE1α, PERK and ATF6. In vivo studies in the ﬂy showed that Cdk5 phos-
phorylates MEKK1 (human ortholog = MAP3K4) to activate the JNK
signaling pathway in response to ER stress. Ablation of this pathway de-
layed age-associated retinal degeneration in the Drosophila model of
retinitis pigmentosa, where a rhodopsin mutant mimicking the autoso-
mal dominant allele of affected humans was expressed in the ﬂy eye.
3.3. ER membrane re-organization
Interesting studies from Varadarajan et al. [28] have uncovered a
new cellular stress response characterized by a striking, but reversible,
reorganization of ER membranes that occurs independently of the
UPR, resulting in impaired ER transport and function that culminatesin cell death. ER membrane aggregation was regulated, in part, by
anti-apoptotic Bcl-2 family members, particularly Mcl-1. Using connec-
tivity mapping, they reported the widespread occurrence of this stress
response by identifying several structurally diverse chemicals from dif-
ferent pharmacological classes, including antihistamines, antimalarials,
and antipsychotics, which induce ER membrane reorganization. Fur-
thermore, they demonstrated that ERmembrane aggregation can result
in pathological consequences.
4. Suppressors of ER-stress induced apoptosis
4.1. Bax-inhibitor 1 (BI-1/Tmbim6)
BI-1 (Tmbim6) is a highly conserved multi-transmembrane protein
that resides predominantly in the ER. BI-1 has been characterized as a
pro-survival protein in the context of ER stress. This pro-survival prop-
erty has been demonstrated against a plethora of cellular insults such as
Ca2+ ﬂuctuations, reactive oxygen species, cytosolic acidiﬁcation, accu-
mulation of unfolded proteins, oxygen deprivation, and alterations in
metabolism [29]. The physiological relevance of BI-1 was ﬁrst described
by Chae et al. who demonstrated that BI-1 suppresses an apoptosis
pathway linked to ER stress in diverse types of cultured cells and in
mice in vivo [30]. In contrast, BI-1-deﬁcient cells displayed high sensi-
tivity to apoptosis induced by ER stress agents such as thapsigargin
and tunicamycin, but not to stimulators of the extrinsic and intrinsicmi-
tochondrial pathways of cell death. In the same study, it was also shown
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associate with Bcl-2 family members (Bcl-2/Bcl-XL) and operate down-
stream of these proteins to regulate ER Ca2+ homeostasis [31]. Cells
over-expressing BI-1 have reduced luminal concentrations of Ca2+ in
the ER, whereas cells in which BI-1 is ablated have higher steady-state
levels of free Ca2++ in the ER. Reconstitution of a C-terminal peptide
of BI-1 in lipid-bilayers has suggested that BI-1may form a Ca2+ perme-
able pore that accounts for its ability to increase the passive leakage rate
of Ca2+ from the ER [32], but other data point to a role for BI-1 in mod-
ulating Ca2+ ﬂux via IP3Rs [33]. Recently, our group has demonstrated
that BI-1 modulates bioenergetics via an IP3R-dependent manner, pre-
sumably by impacting the extent to which Ca2+ is shuttled from ER
into mitochondria via IP3Rs at sites of contact of these organelles [24].
It has been reported that BI-1 suppresses IRE1α activity in both ﬂy
and mouse models of ER stress by forming a complex with IRE1α,
which then nulliﬁes its endoribonuclease activity [34]. For instance,
knocking out the gene encoding BI-1 consistently led to hyperactivity
of the IRE1α pathway. Conversely, cells over-expressing BI-1 showed
reduced IRE1α kinase and endoribonuclease activity, whereas a
C-terminal mutant of BI-1 that fails to bind IRE1α did not suppress
IRE1α activity and lacked cytoprotective activity. Stress kinase activa-
tion induced by ER stress is also blunted by BI-1 [35], which has impli-
cations for control of both cell death and autophagy. Additionally, BI-1
deﬁciency also increases the ER/Golgi expansion and the secretory ac-
tivity of primary B cell, functions controlled by XBP-1, a major down-
stream effector of IRE1α.
In summary, BI-1 appears to provide cytoprotection against ER
stress through two mechanisms: (a) regulation of the resting ER Ca2+
levels and (b) inhibition of IRE1α signaling (which initiates stress ki-
nase activation) (Fig. 2). It remains to be determined whether or not
these two roles synergize to confer the cytoprotective beneﬁts of BI-1
against ER stress. To this end, an analysis of BI-1 mutants that differen-
tially abrogate either ER Ca2+ regulation or IRE1α endoribonuclease ac-
tivity would be highly informative for comparing the relative roles of
these two functions as pertains to cytoprotection against ER stress.
Another member of the Tmbim family, Tmbim-3, has also recently
been implicated in regulation of ER Ca2+ but not IRE1〈 signaling [36].BI-1
IRE1
XBP-1
CELL SURVIVAL
CELL ADAPTATION
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JNK/p38
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α
Fig. 2. Dual function of BI-1 in ER stress and autophagy. BI-1 modulates ER stress and autop
IRE1α, which then nulliﬁes both its endoribonuclease (XBP-1) and kinase activity (JNK). Vi
which causes a corresponding decline in mitochondrial Ca2+ levels and reduces mitochondr
sensor AMPK, which activates autophagy via effects on Atg1 (Ulk1/Ulk2). BI-1 has also been
inﬂuence autophagy.Thus, redundancy of BI-1 (Tmbim6) and Tmbim3 should be considered
in interpreting data where either of these genes was knocked-out or
their expression was experimentally silenced.
4.2. Bcl-2/Bcl-XL
In addition to their role in the mitochondrial pathway of apopto-
sis, Bcl-2 proteins such as Bcl-2 and Bcl-xL also localize at the ER
membrane and are protective against ER stress. It is believed that
this cytoprotective function is mainly due to the ability of Bcl-2 to
lower steady-state levels of ER Ca2+ via IP3Rs. The protective role of
Bcl-2 in regulating ER Ca2+ can be inhibited by JNK-mediated phos-
phorylation [37]. Phosphorylated Bcl-2 loses its anti-apoptotic func-
tion by failing to bind to pro-apoptotic “BH3-only” members of the
Bcl-2 family and/or increasing Ca2+ release from the ER, which is as-
sociated with mitochondria Ca2+ uptake and apoptosis. It has been
reported that the pro-apoptotic proteins Bax and Bak also localize at
the ER where they antagonize the ER Ca2+ modulating activities of
Bcl-2 and Bcl-XL [38]. Additionally, Bax and Bak reportedly bind to
IRE1α, resulting in its pathological activation [22], which in turn is
neutralized by anti-apoptotic Bcl-2 or Bcl-XL. Finally, given that
CHOP induces expression of pro-apoptotic BH3-only protein Bim
during ER stress, anti-apoptotic proteins such as Bcl-2 and Bcl-XL are
likely to play protective roles against ER stress at other levels, as well.
4.3. MicroRNAs
Emerging data have suggested that microRNAs can either modulate
ER stress or be activated by ER stress. For example, PERK-mediated in-
duction of miR30c-2* is stimulated upon ER stress and is correlated
with down-regulation of XBP-1 splicing and commitment to cell death
[38]. In contrast, miR-211 has also been identiﬁed as a PERK target
that facilitates pro-survival responses. Chitnis et al. showed that the
microRNAs miR-221 is associated with CHOP-mediated apoptosis
during ER stress [39]. In this regard, ER stress-induced apoptosis was
reportedly enhanced by miR-221/222 mimics and attenuated by
miR-221/222 inhibitors. Promotionof apoptosis bymiR-221/222 duringBcl-2 ER [Ca2+]IP3R
AUTOPHAGY
AMPK
MITOCHONDRIA [Ca2+]
ATP
hagy by independent mechanisms. BI-1 suppresses IRE1α by forming a complex with
a an IP3R-dependent mechanism, BI-1 also reduces the steady-state levels of ER Ca2+,
ia bioenergetics. Reduction in ATP levels (rise in AMP) activates the intracellular energy
shown to associate with Bcl-2 to regulate Ca2+ homeostasis, which could also indirectly
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cycle regulation. Moreover, Behrman et al. elegantly demonstrated that
CHOP regulatesmiR-708,which plays a homeostatic role inmammalian
rod photoreceptor cells, by preventing excessive rhodopsin loads on the
ER [40]. Additionally, spliced XBP-1 is necessary for ER stress-associated
miR-346 induction. The target genes of miR-346 regulate immune re-
sponses and include the major histocompatibility complex (MHC)
class I gene products, interferon-induced genes, and the ER antigen pep-
tide transporter 1 (TAP1). Because TAP function is necessary for proper
MHC class I-associated antigen presentation, this study provided a
novel mechanistic explanation for reduced MHC class I-associated anti-
gen presentation during ER stress. Recently, it was found that sustained
IRE1α RNAse activity causes rapid decay of microRNAs (miR-17,−34a,
−96 and−125b) that normally repress caspase-2mRNA [41]. Themo-
lecular mechanisms and implications of microRNAs and ER stress re-
sponse await further investigation.4.4. Additional suppressors of ER stress-induced apoptosis
Stimulation of cell surface TNF-family death receptors activates
caspase-8, which targets a limited number of substrates including
Bap31, an integral membrane protein of the ER. The p20 caspase cleav-
age fragment of Bap31 can direct pro-apoptotic signals between the ER
andmitochondria. Adenoviral expression of p20 caused an early release
of Ca2+ from the ER, concomitant uptake of Ca2+ into mitochondria,
and mitochondrial recruitment of Drp1, a dynamin-related protein
that mediates scission of the outer mitochondrial membrane, resulting
in dramatic fragmentation and ﬁssion of the mitochondrial network.
Moreover, prolonged expression of p20 on its own ultimately induced
caspase activation and apoptosis through the mitochondria-initiated
apoptosome pathway. Therefore, it has been suggested that caspase-8
cleavage of Bap31 at the ER stimulates Ca2+-dependent mitochondrial
ﬁssion, enhancing the release of cytochrome c [42]. Additional studies
demonstrated that tumor cell resistance to ER stress-induced apoptosis
was partially mediated by expression levels of calnexin and its associa-
tion with Bap31, with calnexin suppressing Bap31 cleavage [43].
The Bag (Bcl-2 associated athanogene) protein family consists of 6
evolutionary conserved polypeptides (Bag1-Bag6) [44]. They share at
least one copy of the BAG domain consisting of three alpha helices
that interact with and modulate the activity of the molecular chaper-
one Hsp70. Several of the Bag proteins have been implicated in the
control of apoptosis. Bag5 is overexpressed in malignant prostate tis-
sue and its levels are increased following ER-stress induction. Upon
ER stress, Bag5 relocates from the cytoplasm to the ER and interacts
with the ER-resident chaperone BiP and enhances its ATPase activity.
Bag5 over-expression in prostate cancer cells reportedly inhibits
ER-stress induced apoptosis in the unfolded protein response by sup-
pressing PERK-eIF2-ATF4 activity, while enhancing the IRE1α-XBP1
axis of this pathway. Cells expressing high levels of Bag5 showed re-
duced sensitivity to apoptosis induced by different agents, whereas
Bag5 down-regulation resulted in increased stress-induced cell
death [45].
Bifunctional Apoptosis Regulator (BAR) is amulti-domain protein that
was originally identiﬁed as an inhibitor of Bax-mediated cell death. BAR is
highly expressed in the brainwhere it exerts a cytoprotective role against
many apoptotic stimuli including ER stress [46]. The mechanistic role of
BAR in protecting against ER stress was delineated by Rong at al., who el-
egantly demonstrated that BAR is an ER-associated E3 ubiquitin ligase
that stimulates turnover of the BI-1 protein. Speciﬁcally, BAR functions
as an ER-associated RING-type E3 ligase, interacts with BI-1, promoting
BI-1's degradation and therefore removing an inhibitory inﬂuence on
IRE1α signaling. Moreover, the rapid decline of BAR protein levels during
ER stress suggests that post-translational modiﬁcation of BI-1 is dynamic
and could contribute to the selective control of IRE1α signaling in cell un-
dergoing prolonged ER stress [47].5. ER stress and autophagy
ER stress leads to activation of two protein degradation pathways,
the ubiquitin-proteasome via ERAD and lysosome-mediated protein
degradation via autophagy (reviewed in [48]). ERAD involves retro-
translocation of unfolded ER proteins to the cytosol where they are
ubiquitinated and degraded by the proteasome. When the buildup of
misfolded or unfolded proteins exceeds the ER capacity, autophagy
can be induced as a secondary response to degrade accumulated pro-
teins and thus alleviate ER stress. Although ERAD is recognized as the
predominant cellular mechanism for removal of unfolded proteins in
the context of ER stress, a diversity of studies have shown that autoph-
agy can be potently activated by ER stress (Fig. 3).
Autophagy is the process by which cellular macromolecules and
organellar components are sequestered within double membrane vesi-
cles and delivered to lysosomes for degradation and recycling of bioen-
ergetic substrates. Pioneering studies in yeast delineated many of the
essential components of the autophagic machinery, subsequently con-
ﬁrmed and extended in mammalian systems [49]. Formation of the
autophagosomemembrane requires the sequential action of numerous
proteins involved in vesicle nucleation, elongation, fusion with lyso-
somes and ﬁnal degradation of engulfed substrates. The ﬁrst regulatory
process involves suppression of the mTOR Ser/Thr kinase, which blocks
autophagy by phosphorylation of Atg13, and dissociation of this protein
from a complex formed by Atg1 (a protein kinase) and Atg17. Thus,
when mTOR becomes inhibited, for instance by rapamycin, autophagy
is induced. The primary step of vesicle nucleation is the activation of
Vps34, a class III phosphatidylinositol 3-kinase, which associates with
a complex formed by Beclin-1, UV irradiation resistance-associated
tumor suppressor gene (UVRAG) and the kinase Vps15/p150. Beclin-1
can also interact with the anti-apoptotic protein Bcl-2 at the ER, with
Bcl-2 inhibiting starvation-induced autophagy [50]. The next phase of
elongation involves two ubiquitin-like conjugation steps. First, the
proteins Atg12 and Atg5 are covalently conjugated together, with the
cooperation of Atg7 (E1-like) and Atg10 (E2-like). Second, conjugation
of Atg8 with phosphatidylethanolamine (PE) in the membranes of au-
tophagic vesicles occurs following its proteolytic cleavage by Atg4, a
cysteine protease [51]. The subsequent recruitment of Atg8 and other
autophagy-related proteins is believed to trigger vesicle expansion in
a concerted manner, presumably by providing the driving force for
membrane curvature [52]. The transient conjugation of Atg8 to the
membrane lipid PE is essential for phagophore expansion as its muta-
tion leads to defects in autophagosome formation [53]. It is distributed
symmetrically on both sides of the autophagosome and it is assumed
that there is a quantitative correlation between the amount of Atg8
and the vesicle size [54]. After ﬁnishing vesicle expansion, the
autophagosome is ready for fusion with the lysosome and Atg8 can
either be released from the membrane for recycling or gets degraded
in the autolysosome. In humans, some of the orthologs of yeast autoph-
agy genes have been expanded to form gene families, such as Atg1
(represented by the kinases Ulk1 and possibly Ulk2 in humans), Atg4
(represented by the proteases, Autophagin-1, 2, 3, and 4, also known as
ATG4A, B, C, and D), and Atg8 (homologs in humans include LC3 and
GABARAP). The generation of the PE-conjugated and ATG4-cleaved
formof LC3, denominated LC3-II, has been commonly used as an autoph-
agy marker [55].
The molecular mechanisms that link ER stress to autophagy may
vary, and various groups have proposed different hypotheses by which
these two pathways cross-talk (Fig. 2). For instance, various Ca2+ mobi-
lizing agents such as ionomycin, ATP (via purinergic receptors) and
thapsigargin (an irreversible inhibitor of the ER Ca2+ ATPase) reportedly
inhibit the activity of mTOR, a negative regulator of autophagy, and in-
duce massive accumulation of autophagosomes in a Beclin-1- and
Atg7-dependent manner [56]. In this regard, it has been proposed that
Ca2+ release from the ER stimulates a CamKK/AMPK-dependent path-
way that inhibits mTOR to thus induce autophagy [57]. Additionally,
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Fig. 3. Cross-talk of ER stress and autophagy. ER stress can induce autophagy, through at least two UPR pathways, PERK-elF2α and IRE1α. Activatedα can recruit TRAF2 and ASK1,
which subsequently activates JNK. JNK-mediated phosphorylation of Bcl-2 releases Beclin-1 from its inhibitory interaction with Bcl-2. Free Beclin-1 associates with other members
of the ULK1 complex to promote vesicle nucleation. In parallel, spliced XBP-1 can also trigger transcriptional up-regulation of Beclin-1 expression. The elongation process involves
two ubiquitin-like conjugation systems that promote the assembly of Atg5-Atg12-Atg16L complex and the LC3 processing (cleavage and lipidation). Activated PERK can induce
autophagy through ATF4-driven transcriptional regulation of Atg12 whereas ATF4-mediated CHOP activation can also transcriptionally induce Atg5. Ca2+ release from the ER
lumen through the IP3R can activate CaMKK and subsequently relieves mTOR inhibition on the ULK1 complex.
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by IRE1α interaction with TRAF2 to regulate JNK activation [58].
Recently, it was reported that JNK-mediated phosphorylation of
Bcl-2 causes its release of Beclin-1, thereby allowing autophagy to
proceed [50]. Of note, the autophagy protein Atg12 can associate
with and inhibit Bcl-2 proteins, thereby promoting cell death [59]. In
addition, Sakaki et al. suggested that Ca2+ release from the ER induces
protein kinase C (PKC) activation, inducing autophagy via an mTOR-
independent mechanism [60]. On the other hand, Kouroku and col-
leagues showed that the UPR signaling pathway PERK/elF2α induces
Atg12 expression [61]. PERK has been shown to mediate autophagy
through ATF4-driven transcriptional regulation of ATG genes [62]. Re-
cently, Margariti et al. demonstrated that XBP-1mRNA splicing triggers
autophagy through transcriptional activation of Beclin-1 [63]. In view of
these data, it is plausible to assume that several mechanisms contribute
to functional connections between ER stress and autophagy. Given that
autophagy has been linked to protection from several diseases
(neurodegeneration, diabetes, infectious diseases) and to promotion
of some (cancer) (reviewed in [64]) the linkages between ER stress
and autophagy may have relevance to several diseases.
6. ER stress involvement in diseases
ER stress is a hallmark of many common diseases in conditions
where (a) the stress is so strong and/or prolonged to the point that
cells succumb to death or (b) the ability to overcome ER stress is im-
paired by a pathological condition. Below,wewill discuss some diseases
that are either caused or aggravated by components of the ER stress
response.
6.1. Neurodegenerative diseases
In neurodegenerative diseases such as Alzheimer's and Parkinson's
disease, it has been suggested that ER stress evoked by accumulation ofβ-amyloid plaques and α-synuclein, respectively, plays a causal role in
the pathogenesis of these diseases. In Parkinson's disease, dopaminergic
neurons areﬁlledwith intracytoplasmic inclusions called “Lewis Bodies”.
For instance, phosphorylated PERK and phosphorylated eIF2α were
co-localized with α-synuclein, the main component of Lewis bodies, in
dopaminergic neurons of Parkinson's disease patients [65]. Additionally,
Parkinson mimetic drugs (such as 6-hydroxydopamine) increased ER
stress in dopaminergic neurons whereas a null mutation in CHOP re-
duced the 6-hydroxydoamine-induced apoptosis in vivo [66]. Histopath-
ological analyses of brains of Alzheimer's patients have hinted that ER
stress may be a component of the pathogenesis of this neurodegenera-
tive disease. For instance, both spliced XBP-1 and phosphorylated
IRE1α were found in the brains of individuals with Alzheimer's disease
[67,68]. Moreover, β-amyloid induces CHOP expression both in cultured
cells and animal brains, whereas treatment of cells with CHOP antisense
RNA improved neuronal survival after exposure to β-amyloid [69]. Re-
cent studies with autopsied amyotropic lateral sclerosis (ALS) patients
and studies using mutant superoxide dismutase (mSOD1) transgenic
mice have suggested that ER stress-related toxicity may also be highly
relevant to this degenerative disease that destroys spinal motoneurons
[70].
6.2. Ophthalmology disorders
A growing number of reports have suggested that accumulation of
misfolded proteins plays an important role in the pathogenesis of several
eye diseases such as retinitis pigmentosa, glaucoma, andmacular degen-
eration. Retinitis pigmentosa (RP) is an age-related retinal degenerative
disease caused by mutant rhodopsins. In a rat model of RP expressing
rhodopsin-P23H, levels of ATF6, phosphorylated elF2α and CHOP were
elevated when compared to control animals. Over-expression of BiP
and components of the ERAD machinery in this mouse model reduced
CHOP expression and ameliorated the electrical response of photorecep-
tors, suggesting that ER stress plays a major pathological role in this
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choroidal neovascularization promoted by increased VEGF and capil-
lary leakage cause ﬂuid exudation, hemorrhages, and ﬁbrotic scars,
thereby damaging photoreceptors and causing vision loss. Oxidative
stress, inﬂammation and ER stress have been shown to play a combi-
natory effect in the pathogenesis of AMD. As an example, high levels
of oxidized proteins, lipids, and nucleic acids in AMD lesions can ac-
tivate a local inﬂammatory response, which in turn can stimulate ER
stress. In fact, AMD lesions, also named drusens, contain high levels
of oxidated LDLs, which stimulate VEGF expression via the PERK/
ATF4 signaling pathway [72]. Moreover, therapy with chemical
chaperones such as TMAO (trimethylamide-N-oxide) has been dem-
onstrated to alleviate protein aggregation in AMD [73]. Last, in a
mouse model of primary open angle glaucoma harboring the most
common mutation in Myocilin, reduction of ER stress with chemical
chaperones prevented cell death by promoting secretion of mutant
Myocilin in the aqueous humor and by decreasing intracellular accu-
mulation of Myocilin in the ER [74].
6.3. Inﬂammation
ER stress pathways are closely linked to mechanisms involved in im-
munity and inﬂammation. IRE1α can be phosphorylated by signals
downstreamof Toll-like receptors (TLRs) to induceXBP-1mRNA splicing
and support production of proinﬂammatory cytokines in macrophages
[75]. On the other hand, TLR signaling can also inhibit ATF6 and CHOP
in macrophages [76]. Unfolded protein accumulation has also been de-
scribed in many autoimmune diseases, including inﬂammatory bowel
disease (IBD), multiple sclerosis, and rheumatoid arthritis [77]. With re-
spect to theUPRmachinery, Kaser et al. [78] reported that XBP-1 deletion
in intestinal epithelial cells (IEC) results in spontaneous enteritis and
overactive responses of IECs to IBD inducers, TNFα and ﬂagellin. This
phenotype was attributed to the inability of XBP-1-deﬁcient IEC to gen-
erate antimicrobial activity and respond properly to inﬂammatory sig-
nals in the local milieu. Additionally, this study also identiﬁed several
single nucleotide polymorphisms (SNPs) within the XBP-1 gene locus
that conferred high risk for both types of IBD, Crohn's disease and ulcer-
ative colitis.
Though better known for its role in sensing viral RNA in the context
of innate immune responses that stimulate interferon production, the
double-strand RNA-dependent protein kinase (PKR) is also reportedly
activated by ER stress [79]. When activated, PKR, similarly to PERK,
phosphorylates elF2α, which leads to shutdown of protein synthesis
and inhibition of viral replication [80]. Moreover, PKR has also been
shown to participate in inﬂammasome activation and the cytokine
HMGB1 release. Studies from Lu et al. [81] reported that PKR broadly
regulates inﬂammasome activation by phosphorylating members of
the NLR (Nucleotide binding, Leucine rich repeat Receptors), including
NLRP3 (NLR family pyrin domain-containing 3), NLRP1, and NLRC4
(NLR family CARD domain-containing protein 4).
Using a combination of genetic, pharmacological, and biochemical
approaches, Lee et al. [82] convincingly demonstrated that murine
calcium-sensing receptor (CASR) has a major role in NLRP3
inﬂammasome activation through its effects on ER Ca2+ (IP3R-mediated)
and cAMP. Brieﬂy, Ca2+ and other CASR agonists activated the NLRP3
inﬂammasome whereas knockdown of CASR reduced inﬂammasome
activation in response to NLRP3 activators. CASR activates the
inﬂammasome via an IP3-mediated mechanism that releases ER Ca2+
stores. Understanding the precise mechanisms linking ER Ca2+ release
to inﬂammasome activation is a topic that merits further elucidation.
6.4. Viral infections
In the course of viral infection a large number of viral proteins,
especially glycoproteins, are synthesized allowing viral replication
and maturation. This high demand for proteins triggers ER stressleading to both cell survival and cell death. Expect for BiP, which
seems to be induced in most of the viral infections [83], different vi-
ruses may induce a speciﬁc UPR response. For instance, cytomegalovi-
rus (CMV) infection inhibits ATF6 pathways but activates the IRE1α
pathway as an alternative mechanism to upregulate the expression
of chaperones. The transcriptional activation of XBP-1 target genes
is inhibited in order to prevent viral proteins in the ER from being de-
graded [84]. On the other hand, viruses such as the herpes simplex
virus 1 (HSV1) are known for disarming the activation of PERK. In
fact, the γ134.5, a virulence factor encoded by herpes simplex viruses,
plays an important role in inhibiting elF2α phosphorylation and alle-
viating the translation arrest in mammalian cells treated with
thapsigargin and DTT [85]. Additionally, replication of hepatitis C
virus (HCV) has been shown to stimulate the ATF6 pathway but in-
hibit the IRE1α/XBP-1 pathway. Interestingly, several viruses have
been shown to induce ER stress-mediated apoptosis. Infection of
Japanese encephalitis virus triggers p38 MAPK, CHOP activation, and
cell death and is inhibited by over-expression of Bcl-2 [83]. Similarly,
a cytopathic strain of bovine diarrhea virus induces apoptosis via
CHOP and phosphorylation of PERK and elF2α [83].
6.5. Cancer
The tumor microenvironment is characterized by poor vasculariza-
tion, low oxygen supply, nutrient deprivation, and acidic pH — all of
which are activators of ER stress. In rapidly growing cancers, UPR has
been shown to exert an important cytoprotective role that assists
folding of newly synthesized proteins necessary for tumor growth.
Among the UPR branches, IRE1α and PERK are important for tumor
cell survival and growth under hypoxic conditions. Tumors derived
from PERK-deﬁcient transformed mouse embryonic ﬁbroblasts
(MEFs) show evidence of increased cell death rates and impaired ability
to stimulate angiogenesis. More convincingly, the importance of PERK/
elF2α-mediated UPR signaling was supported by a study with MEFs
that expressed a non-phosphorylated form of elF2α that impaired cell
survival under extreme hypoxia [86]. The IRE1α/XBP-1 pathway has
been shown to be crucial for angiogenesis in the early stages of tumor
development, as evidenced by studies where the expression of a
dominant-negative from of IRE1α or inhibition of XBP-1 splicing by
RNAi reduced blood vessel formation in a human tumor xenograft
model [87]. Inhibition of the IRE1α/XBP-1 pathway has been explored
recently as a target for anticancer therapy. For instance, small molecules
that inhibit IRE1α-mediated XBP-1 splicing signiﬁcantly suppressed
multiple myeloma cell growth in an animal model [88]. Moreover, the
transcriptional activity of XBP-1, which has been previously shown to
be required for plasma cell differentiation [89], is reportedly suppressed
by proteasome inhibitors in myeloma cells [90]. XBP1 inhibition was
associated with high levels of apoptosis, suggesting a role of this
transcription factor in perpetuating this malignancy. Furthermore,
over-expression of BI-1, another modulator of IRE1α, has been shown
to promote tumor growth in a tumor xenograft model [91,92]. Finally,
elevated levels of the ER chaperone BiP in cancer cell lines and clinical
tumor specimens are frequently present in a diverse variety of malig-
nancies, with expression correlated with pro-survival mechanisms,
chemoresistance to therapy, and poor prognosis [93].
6.6. Metabolic diseases
ER stress plays an important role in the capacity of cells to deal
with nutrient ﬂuctuations and additionally some nutrients such as
saturated fats induce ER stress. For example, high fat diet (HFD) is a
well-known inducer of UPR and pathological ER stress signaling
(reviewed in [94]). In fact, mice fed with HFD and the severe ob/ob
mouse model of genetic obesity show elevated phosphorylated
PERK and IRE1α and JNK activation in both adipose tissue and liver
[95,96]. Moreover, studies from Teodoro-Morrison, et al. showed
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against glucose intolerance and insulin resistance caused by obesity.
Liver and muscle tissues from leptin-receptor deﬁcient (db/db) mice
have reduced BI-1 mRNA expression. Conversely, restoration of he-
patic BI-1 protected mice from obesity-associated insulin resistance
and glucose intolerance due to suppression of the downstream
IRE1α signaling [97]. ER stress caused by HFD has also been implicat-
ed in insulin resistance mechanisms of relevance to type 2 diabetes
(T2DM). Genetic ablation of XBP-1 caused increased sensitivity to
ER stress, insulin resistance, and degradation of the insulin receptor
substrate-1 (IRS-1), uncoupling it from the insulin receptor signaling
[98]. Additionally, stress kinase activation as a result of ER stress (in
the context of HFD and obesity) results in serine phosphorylation of
IRS-1, uncoupling it from insulin receptor signaling and promoting
insulin resistance [97,99].
UPR has also been suggested to participate in carbohydrate metabo-
lism, which has been evidenced in studies of T2DM. For instance, ER
stress can inhibit STAT-3-dependent suppression of gluconeogenic en-
zymes and play an important role in the increase of hepatic glucose pro-
duction in obesity and diabetes [100]. Work fromWang et al. [101] has
also shown that acute ER stress triggered the phosphorylation and nu-
clear entry of CRTC2, which in turn promoted the expression of ATF6
and activated gluconeogenesis. Yoshizawa et al. [102] have also re-
vealed that ATF4 alters glucose metabolism by increasing insulin sensi-
tivity in liver, adipose, and muscle tissues.
Recent studies in T2DM have demonstrated a direct involvement of
UPR in the death of pancreatic β-cells. Due to high insulin demand,
β-cells greatly rely on the ER to ensure synthesis and proper folding of
pro-insulin. The involvement of UPR and, more speciﬁcally the
PERK-eIF2α pathway, was revealed by studies in PERK-null mice and
in the human disease Wolcott–Rallison syndrome, a rare infantile-
onset insulin-requiring diabetes caused by a loss-of-function mutation
in the PERK gene [103]. For instance, PERK-deﬁcient pancreatic β-cells
are more sensitive to ER-stress induced apoptosis and PERK deﬁcient
mice develop neonatal hyperglycemia caused by islet proliferation de-
fects and increased apoptosis [62]. Additionally, mice defective in the
elF2α phosphorylation develop diabetes due to unregulated proinsulin
translation, increased oxidative damage, reduced expression of
β-cell-speciﬁc genes, and apoptosis [104].
Advanced glycation end products (AGEs) are caused under condi-
tions of oxidative stress and hyperglycemia, typical features of T2DM.
Glycated proteins function abnormally and have been reported to induce
ER stress as evidenced by increasing levels of Grp78 and apoptosis in ad-
ipocytes treated with glycated serum albumin. In addition, the ER stress
inhibitor taurine conjugated ursodeoxycholic acid (TUDCA), which acts
as a chaperone that promotes the folding and trafﬁcking of unfolded or
malfolded proteins, prevents AGE-induced apoptosis [105]. Like glycated
albumin, extracellular matrix is frequently modiﬁed by advanced
glycation in the skin of diabetic patients. The advanced-glycated type I
collagen also causes pro-apoptotic UPR-mediated apoptosis via CHOP ac-
tivation in dermal ﬁbroblasts, suggesting a pathophysiological role for
the link between advanced glycation and ER stress in diabetic wounds
[106].
In a diabetes context, Oslowski et al. reported that thioredoxin-
interacting protein (TXNIP)was induced by ER stress through the action
of both IRE1α and PERK. In turn, TXNIP promoted IL-1β production by
the NLRP3 inﬂammasome and in pancreatic β-cells [107]. Simulta-
neously, Lerner et al. showed that IRE1α increases TXNIP mRNA stabil-
ity by reducing levels of TXNIP destabilizing microRNA, miR-17, thus
activating the NLRP3 inﬂammasome, causing procapase-1 cleavage,
and IL-1β secretion [108]. It has also been shown that mice with
XBP-1 deﬁciency in β-cells have hyperglycemia and glucose intoler-
ance, with features of diabetes. Moreover it has been demonstrated
that PKR can be activated by ER stress. PKR coordinates the activity of
inﬂammatory cytokines and insulin receptor signaling through mecha-
nisms that are only partly understood [81].6.7. Atherosclerosis
In atherogenesis, arterial wall stressors such as oxidative stress and
subendothelial retention of apolipoprotein B-containing lipoproteins
trigger the expression of adhesion molecules, cytokines and
chemokines in endothelial cells, leading to attraction of inﬂammatory
cells, mainly macrophages. The macrophages internalize lipoproteins
and undergo apoptosis, which in turn leads to secondary necrosis. Re-
cently, ER stress has emerged as an important component that inﬂu-
ences the course of atherosclerosis, particularly in the advanced stages
of the disease. Analyses of human atherosclerotic plaques and animal
studies have shown clear evidence of ER stress in macrophages and en-
dothelial cells, the major cells implicated in atherogenesis. For instance,
both free cholesterol and 7-ketocholesterol cause ER stress-mediated
macrophage apoptosis though activation of CHOP. Conversely, both in
vivo and in vitro models demonstrated that genetic silencing of CHOP
leads to a reduction in macrophage death with decreases in plaque
rupture [109,110]. The IRE1α/ASK1/JNK pathway contributes to
CHOP-mediated macrophage death. For instance, Western diet-fed
Apolipoprotein E null mice treated with an IRE1α small interfering
RNA or with a JNK inhibitor showed reduced cholesterol-induced mac-
rophage death. The involvement of ER stress in atherosclerosis patho-
genesis was also supported by chemical studies using chaperones. In a
genetic model of hypercholesterolemic atherosclerosis associated with
apolipoprotein E deﬁciency, administration of a chemical chaperone
(phenyl butyric acid) reduced vascular lesion damage and macrophage
apoptosis in vivo and in vitro. Furthermore, the same study also showed
that mitigation of ER stress prevented macrophagic fatty-acid-binding
protein-4 expression, an important component of lipid toxicity in mac-
rophages [111].
ER stress mechanisms may also be relevant to heart disease in the
context of both ischemia-reperfusion injury (myocardial infarction)
and heart failure. For example, in models of cardiac hypertrophy
(heart failure) caused by aortic banding, ER stress has been implicat-
ed as a mechanism responsible for cardiomyocyte apoptosis [112].
Chemical chaperones that relieve ER stress also reduce cardiomyocyte
apoptosis in the aortic banding model in rodents [113]. Interestingly,
β-adrenergic receptor blockers have been reported to ameliorate ER
stress in heart failure models, probably through their effects on ER
Ca2+ dynamics [114]. Ask1−/− mice are protected from heart failure
caused by aortic banding, showing less cardiomyocyte apoptosis in
vivo [115], which further suggests the likely involvement of ER stress
in heart failure given the prominent role of this apoptotic kinase
downstream of IRE1α activation.
ER stress is also clearly activated during myocardial infarction
(reviewed in [116]). ATF6 plays a cardioprotective role in this context
[13], while IRE1α pathway-mediated ER stress seems to be destruc-
tive. For example, the apical kinase in the IRE1α stress kinase path-
way ASK1 plays a prominent role, in that Ask1−/− mice showed
preservation of left ventricular function compared to wild-type con-
trols after coronary arterial ligation [115].
7. Conclusions and future perspectives
Cellular stress responses are a fundamental part of a normal cell
physiology. In fact, the adaptation to the “adversity” has greatly shaped
the evolution of multi-cellular organisms and has likely promoted the
emergence of diverse cellular resilience mechanisms. Whether or not
stress culminates in cell death survival or death is determined by mul-
tiple different factors, such as intensity and longevity of stress, cell
type, and other environmental factors.
The ER is a highly dynamic organelle that exerts a major role in
coordinating signaling pathways that ensure cell adaptation, cellular
resilience, and survival. Although increasing evidence has suggested
that numerous diseases are caused by abnormal cellular responses
to ER stress, many questions remain unanswered regarding the
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ideal for enabling cellular adaptation and survival? To what extent
are the adaptive versus destructive UPR and non-UPR responses to
ER stress involved in the pathophysiology of diseases? How can we
selectively modulate the ER stress responses in sick but not healthy
cells? And ﬁnally, how does the ER interconnect with other cellular
organelles to modulate cell death?
Evidence for a role of ER stress-mediated cell death in a variety of
diseasesmake this process an attractive target for therapy. In particular,
small molecule inhibitors of the kinase-components of the UPR, PERK
and IRE1α, are potential druggable candidates for cancer. On the other
hand, players in the IRE1α-TRAF2-ASK1 pathway could also be targets
for preventing death of neurons and cardiomyocytes. However,
targeting only one branch of the ER stress pathway might not be sufﬁ-
cient to prevent cell death. Thus, a better understanding of the mecha-
nisms that orchestrate the ER stress responses may help to devise
future strategies of safely modulating this process for therapeutic
beneﬁt.
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